Measurements fail to identify TB patients who could benefit from shorter treatment course

Jun 30, 2009

Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs in resource-limited settings with poor public health infrastructures.

Testing whether two simple clinical measurements might help identify which TB patients could benefit from shorter treatment, researchers at Case Western Reserve University and University Hospitals (UH) Case Medical Center report that these measurements failed to work in a study published online by the .

The two measurements were absence of a cavity (an abscess caused by TB) in the lungs (detected by chest X-ray) and failure to grow from the sputum once drug treatment was started (sputum culture conversion). The Phase III clinical trial involved TB patients in Uganda (Africa), Brazil (S. America) and the Philippines (Asia) and was conducted by the Research Unit (TBRU) at Case Western Reserve University and UH Case Medical Center in Cleveland, the only National Institutes of Health supported TB unit in the U.S.

"We found that combining these two clinical measurements failed to select TB patients who could benefit from shorter drug treatment. TB patients receiving four months of TB treatment had their disease come back much more often than those who got six months of drug treatment," said W. Henry Boom, M.D., an infectious disease expert with Case Western Reserve University and UH Case Medical Center and Director of the TBRU. "This study points out the limitations of current clinical measures to identify the relatively small group of TB patients who respond poorly to standard drug treatment."

"To better identify risk factors for why treatment fails in a subset of TB patients will require novel approaches and further research so that we can determine quickly (not having to wait for two years after completing six months of drug treatment to measure relapses) not only the effectiveness of new TB drugs or regimens but also who will benefit most from these shortened and simplified TB treatment regimens," added John L. Johnson, MD, first author of the study and an infectious disease expert with Case Western Reserve University School of Medicine and UH Case Medical Center.

Source: University Hospitals Case Medical Center

Explore further: Norovirus in food outlets to be mapped for first time

add to favorites email to friend print save as pdf

Related Stories

Researchers urge integrating TB into HIV care

Jul 22, 2008

In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention ...

WHO warns of drug-resistant TB

Sep 06, 2006

The World Health Organization in Switzerland has warned of a new strain of tuberculosis that is rapidly spreading and cannot be treated with current drugs.

HIV/AIDS linked to drug resistant TB

Nov 16, 2006

U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.

Extensively drug-resistant tuberculosis found in California

Aug 13, 2008

In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and ...

Drug-resistant tuberculosis rife in China

Dec 11, 2008

Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average. Nationwide research published in the open access journal BMC Infectious Diseases has shown that almost 10% of Chinese TB cases are re ...

Recommended for you

Impact of whooping cough vaccination revealed

2 hours ago

The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria's origin and evolution. The new results ...

Saudi announces 11 new MERS infections

6 hours ago

Saudi Arabia on Wednesday announced 11 new cases of MERS, including a 13-year-old child, as its acting health minister vowed to keep the public better informed on the coronavirus.

User comments : 0

More news stories

Deliberation is staunchest ally of selfishness

(Medical Xpress)—Over the last two years, Yale psychologist David Rand and colleagues have investigated what makes people willing to help each other. Their latest research shows that while initial reactions ...

Researchers compare hip width and sexual behavior

In a new study, women who were more inclined to have one-night stands had wider hips, reveals Colin A. Hendrie of the University of Leeds in the UK. He is the lead author of a study into how a woman's build influences her ...

How many moons does Venus have?

There are dozens upon dozens of moons in the Solar System, ranging from airless worlds like Earth's Moon to those with an atmosphere (most notably, Saturn's Titan). Jupiter and Saturn have many moons each, ...